These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22516407)

  • 21. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury.
    Briguori C; Visconti G; Focaccio A; Airoldi F; Valgimigli M; Sangiorgi GM; Golia B; Ricciardelli B; Condorelli G;
    Circulation; 2011 Sep; 124(11):1260-9. PubMed ID: 21844075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.
    Majumdar SR; Kjellstrand CM; Tymchak WJ; Hervas-Malo M; Taylor DA; Teo KK
    Am J Kidney Dis; 2009 Oct; 54(4):602-9. PubMed ID: 19535188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal protection: preconditioning for the prevention of contrast-induced nephropathy.
    Ozsvath KJ; Darling RC
    Semin Vasc Surg; 2013 Dec; 26(4):144-9. PubMed ID: 25220319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trial of Furosemide to Prevent Acute Kidney Injury in Critically Ill Children: A Double-Blind, Randomized, Controlled Trial: Correspondence.
    Khera D; Paul B; Goyal JP
    Indian J Pediatr; 2022 May; 89(5):526. PubMed ID: 35157235
    [No Abstract]   [Full Text] [Related]  

  • 25. Contrast nephropathy : an evidence-based approach to prevention.
    Kandzari DE; Rebeiz AG; Wang A; Sketch MH
    Am J Cardiovasc Drugs; 2003; 3(6):395-405. PubMed ID: 14728060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trial of Furosemide to Prevent Acute Kidney Injury in Critically Ill Children: A Double-Blind, Randomized, Controlled Trial: Author's Reply.
    Rameshkumar R
    Indian J Pediatr; 2022 May; 89(5):527. PubMed ID: 35320502
    [No Abstract]   [Full Text] [Related]  

  • 27. New pharmacological protocols to prevent or reduce contrast media nephropathy.
    Briguori C; Airoldi F; Morici N; Colombo A
    Minerva Cardioangiol; 2005 Feb; 53(1):49-58. PubMed ID: 15788979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrast-induced acute kidney injury: potential new strategies.
    Briguori C; Donnarumma E; Quintavalle C; Fiore D; Condorelli G
    Curr Opin Nephrol Hypertens; 2015 Mar; 24(2):145-53. PubMed ID: 25602516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Intraoperative Aminophylline Versus Furosemide in Treatment of Oliguria During Pediatric Cardiac Surgery.
    Onder AM; Rosen D; Mullett C; Cottrell L; Kanosky S; Grossman OK; Iqbal HI; Seachrist E; Samsell L; Gustafson K; Rhodes L; Gustafson R
    Pediatr Crit Care Med; 2016 Aug; 17(8):753-63. PubMed ID: 27355823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Question 1: Is the use of furosemide beneficial in the treatment of acute kidney injury in the paediatric population including neonates?
    Lethaby D; Cyriac J; Bockenhauer D
    Arch Dis Child; 2015 Jul; 100(7):713-5. PubMed ID: 25990499
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevention of Contrast-Induced Nephropathy by Central Venous Pressure-Guided Fluid Administration in Chronic Kidney Disease and Congestive Heart Failure Patients.
    Qian G; Fu Z; Guo J; Cao F; Chen Y
    JACC Cardiovasc Interv; 2016 Jan; 9(1):89-96. PubMed ID: 26685074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydration in contrast-induced acute kidney injury.
    Briguori C; Condorelli G
    Lancet; 2014 May; 383(9931):1786-8. PubMed ID: 24856014
    [No Abstract]   [Full Text] [Related]  

  • 33. Diuretics in acute kidney injury.
    Karajala V; Mansour W; Kellum JA
    Minerva Anestesiol; 2009 May; 75(5):251-7. PubMed ID: 18636060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrast-induced Nephropathy: Essentials and Concerns.
    Samadian F; Dalili N; Mahmoudieh L; Ziaei S
    Iran J Kidney Dis; 2018 May; 12(3):135-141. PubMed ID: 29891742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RenalGuard system in high-risk patients for contrast-induced acute kidney injury.
    Briguori C; Visconti G; Donahue M; De Micco F; Focaccio A; Golia B; Signoriello G; Ciardiello C; Donnarumma E; Condorelli G
    Am Heart J; 2016 Mar; 173():67-76. PubMed ID: 26920598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of Contrast-Induced Acute Kidney Injury: an Update.
    Chalikias G; Drosos I; Tziakas DN
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):515-524. PubMed ID: 27541275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of bilirubin for the prevention of contrast-induced nephropathy.
    Halacli B; Ecder T
    Med Hypotheses; 2009 Feb; 72(2):232-3. PubMed ID: 18945551
    [No Abstract]   [Full Text] [Related]  

  • 38. Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
    Briguori C; Visconti G; Ricciardelli B; Condorelli G;
    EuroIntervention; 2011 Apr; 6(9):1117-22, 7. PubMed ID: 21518686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minimizing the renal toxicity of iodinated contrast.
    McCullough PA; Khambatta S; Jazrawi A
    Circulation; 2011 Sep; 124(11):1210-1. PubMed ID: 21911794
    [No Abstract]   [Full Text] [Related]  

  • 40. [Contrast media-induced nephropathy: clinical burden and current attempts for prevention].
    Habeb M; Ağaç MT; Aliyev F; Pehlivanoğlu S; Ongen Z
    Anadolu Kardiyol Derg; 2005 Jun; 5(2):124-9. PubMed ID: 15939688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.